Daily non-political popular news in brief.

Study produces conflicting findings on the use of anti-anemia drug in cancer patients

Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.

Read more »

Keywords: study, produces, conflicting, findings, anti-anemia, drug, cancer, patients, produce, finding, anti, anemia, patient

« Previous | Next »

Similar news on "Study produces conflicting findings on the use of anti-anemia drug in cancer patients":

1. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
   12-14-2007 · EurekAlert!
   The targeted therapy Herceptin helps women with HER2+ type of breast cancer independent of whether patients have extra copies of chromosome 17, home to the HER2 gene which produces the HER2 protein that fuels cancer growth. Prior to this report, there were conflicting opinions about whether that was the case, say Mayo Clinic investigators who presented their findings at the San Antonio Breast Cancer Symposium.
   Similar news · Read more »
   
2. Penn's Abramson Cancer Center part of major phase III study for myeloma
   11-21-2007 · EurekAlert!
   Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
   Similar news · Read more »
   
3. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
   06-02-2007 · EurekAlert!
   The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT).
   Similar news · Read more »
   
4. Cetuximab may prolong survival for head and neck cancer patients
   01-18-2007 · EurekAlert!
   Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
   Similar news · Read more »
   
5. Could 'hairy roots' become biofactories?
   10-30-2007 · EurekAlert!
   Rice University bioengineers have reported an advance in tapping the immense potential of 'hairy roots' as natural factories to produce medicines, food flavorings and other commercial products. The study, published in next month's Biotechnology Progress, focuses on a species of periwinkle that produces the anti-cancer drugs vincristine and vinblastine. Scientists hope to use the findings to boost production of the drugs.
   Similar news · Read more »
   
6. Personalized diets may offer relief to advanced cancer patients
   03-09-2007 · EurekAlert!
   Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
   Similar news · Read more »
   
7. UCLA study finds prostate cancer treatments impact on quality of life
   04-23-2007 · EurekAlert!
   A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways. The findings provide invaluable information for men with prostate cancer who are facing vital treatment decisions.
   Similar news · Read more »
   
8. Unstable leukemia stem cells may predispose patients to drug resistance
   05-01-2007 · EurekAlert!
   The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
   Similar news · Read more »
   
9. What's going on in the body? Advanced time-of-flight PET takes a superior 'look'
   06-04-2007 · EurekAlert!
   Moving from computer simulation to patient images, researchers are now demonstrating the benefits that time-of-flight/PET imaging can provide for cancer patients. The result? Superior images and shorter patient scan times for starters, according to a study released at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals, June 2-6 in Washington, D.C.
   Similar news · Read more »
   
10. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
    08-20-2007 · EurekAlert!
    A recent study from the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, the Vanderbilt-Ingram Comprehensive Cancer Center and the Sarah Canon Cancer Center in Nashville have identified an unusually high rate of allergic reaction in cancer patients living in the middle South who received a common drug used for treating their cancer.
    Similar news · Read more »